ZIDOVUDINE Side Effects

6668270-7 | Thalassaemia
on Dec 18, 2009 Male patient from , weighting 6.22 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: thalassaemia. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacent) (View Lamivudine Review and Lamivudine Label ).

6667940-4 | Glucose-6-phosphate Dehydrogenase Deficiency, Premature Baby
Patient was taking Zidovudine (View Usage). Patient had the following side effects: glucose-6-phosphate dehydrogenase deficiency, premature baby on Dec 23, 2009 from Additional patient health information: Male patient , weighting 2.87 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacental. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6662589-1 | Sickle Cell Anaemia
Adverse event was reported on Mar 13, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: Unk-unk-transplacental) was diagnosed with hiv infection (What is hiv infection?) and. Location: , weighting 7.74 lb, After Zidovudine was administered, patient had the following side effects: sickle cell anaemia. During the same period patient was treated with LAMIVUDINE (Unk-unk-transplacental) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Unk-unk-transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6662167-4 | Osteonecrosis
on Mar 17, 2010 Male patient from COTE D'IVOIRE , 33 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Zidovudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.


6662165-0 | Osteonecrosis
on Mar 17, 2010 Male patient from COTE D'IVOIRE , 33 years of age, weighting 149.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Zidovudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), KALETRA /01506501/ (View Kaletra /01506501/ Review and Kaletra /01506501/ Label ). Patient was hospitalized.

6656395-1 | Congenital Naevus, Talipes
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: congenital naevus, talipes on Dec 23, 2009 from THAILAND Additional patient health information: Female patient , weighting 8.38 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6656384-7 | Congenital Cytomegalovirus Infection, Sickle Cell Anaemia
Adverse event was reported on Dec 18, 2009 by a Male patient taking Zidovudine (View Usage) (Dosage: Transplacent) was diagnosed with hiv infection (What is hiv infection?) and. Location: THAILAND , weighting 6.19 lb, Patient experienced the following unwanted or unexpected effects: congenital cytomegalovirus infection, sickle cell anaemia. During the same period patient was treated with LAMIVUDINE (Transplacent) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6653667-1 | Plagiocephaly
on Dec 23, 2009 Male patient from , weighting 6.04 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: plagiocephaly. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6653663-4 | Hepatic Cyst, Sickle Cell Anaemia
on Dec 18, 2009 Male patient from THAILAND , weighting 7.10 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: hepatic cyst, sickle cell anaemia. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6653662-2 | Congenital Foot Malformation
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: congenital foot malformation on Dec 23, 2008 from THAILAND Additional patient health information: Male patient , weighting 8.71 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6653660-9 | Atrial Septal Defect, Pulmonary Valve Stenosis
Adverse event was reported on Dec 18, 2009 by a Male patient taking Zidovudine (View Usage) (Dosage: Transplacent) was diagnosed with hiv infection (What is hiv infection?) and. Location: THAILAND , weighting 8.60 lb, Patient had the following side effects: atrial septal defect, pulmonary valve stenosis. During the same period patient was treated with LAMIVUDINE (Transplacent) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6653629-4 | Sickle Cell Anaemia
on Dec 23, 2009 Female patient from UNITED KINGDOM , weighting 7.74 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: sickle cell anaemia. Zidovudine dosage: Transplacental. During the same period patient was treated with LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6653616-6 | Foetal Growth Retardation
on Dec 23, 2009 Female patient from THAILAND , weighting 5.93 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: foetal growth retardation. Zidovudine dosage: Transplacental. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6653615-4 | Inguinal Hernia
Patient was taking Zidovudine (View Usage). Patient had the following side effects: inguinal hernia on Dec 22, 2009 from THAILAND Additional patient health information: Female patient , weighting 7.32 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacent) (View Lamivudine Review and Lamivudine Label ), .. (View .. Review and .. Label ).

6653607-5 | Haemangioma Congenital, Premature Baby
Adverse event was reported on Dec 22, 2009 by a Male patient taking Zidovudine (View Usage) (Dosage: Transplacent) was diagnosed with hiv infection (What is hiv infection?) and. Location: THAILAND , weighting 6.97 lb, After Zidovudine was administered, patient had the following side effects: haemangioma congenital, premature baby. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacent) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6652681-X | Osteonecrosis
on Mar 12, 2010 Male patient from COTE D'IVOIRE , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Zidovudine dosage: Unk. During the same period patient was treated with DIDANOSINE (Unk) (View Didanosine Review and Didanosine Label ), SAQUINAVIR (Unk) (View Saquinavir Review and Saquinavir Label ), STAVUDINE (Unk) (View Stavudine Review and Stavudine Label ), LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NELFINAVIR (Unk) (View Nelfinavir Review and Nelfinavir Label ), EFAVIRENZ (Unk) (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6649241-3 | Haemangioma Congenital
on Dec 18, 2009 Male patient from , weighting 6.46 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: haemangioma congenital. Zidovudine dosage: Transplacent. During the same period patient was treated with VIRACEPT (Transplacent) (View Viracept Review and Viracept Label ).

6649240-1 | Pregnancy
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: pregnancy (What is pregnancy?) on Dec 18, 2009 from Additional patient health information: Male patient , weighting 6.35 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR (Transplacent) (View Nelfinavir Review and Nelfinavir Label ).

6648875-X | Hydrocele
Adverse event was reported on Dec 18, 2009 by a Male patient taking Zidovudine (View Usage) (Dosage: Transplacental) was diagnosed with hiv infection (What is hiv infection?) and. Location: , weighting 7.12 lb, Patient experienced the following unwanted or unexpected effects: hydrocele. During the same period patient was treated with VIRACEPT (Transplacental) (View Viracept Review and Viracept Label ), EMTRICITABINE (Transplacental) (View Emtricitabine Review and Emtricitabine Label ), EFAVIRENZ (Transplacental) (View Efavirenz Review and Efavirenz Label ), TENOFOVIR (Transplacental) (View Tenofovir Review and Tenofovir Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ), LOPINAVIR (Transplacental) (View Lopinavir Review and Lopinavir Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6648727-5 | Hydrocephalus
on Dec 23, 2009 Female patient from , weighting 6.61 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: hydrocephalus (What is hydrocephalus?). Zidovudine dosage: Transplacental. During the same period patient was treated with VIRACEPT (Transplacental) (View Viracept Review and Viracept Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ).

6647822-4 | Congenital Nystagmus
on Dec 23, 2009 Male patient from THAILAND , weighting 7.72 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: congenital nystagmus. Zidovudine dosage: Transplacental. During the same period patient was treated with LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ), LOPINAVIR (Transplacental) (View Lopinavir Review and Lopinavir Label ), NELFINAVIR MESILATE (Transplacental) (View Nelfinavir Mesilate Review and Nelfinavir Mesilate Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ).

6647307-5 | Jaundice, Lipoatrophy
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), lipoatrophy on Mar 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 65 years of age, weighting 180.8 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: . During the same period patient was treated with REYATAZ (300mg Per Day) (View Reyataz Review and Reyataz Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ), DAPSONE (100mg Per Day) (View Dapsone Review and Dapsone Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6644388-X | Abasia, Cataract Congenital, Developmental Delay, Dysmorphism, Growth Retardation, Hyperparathyroidism, Hypotonia, Lactic Acidosis, Mental Retardation
Adverse event was reported on Mar 16, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: ) was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and. Location: , child 4 years of age, Patient had the following side effects: abasia, cataract congenital, developmental delay, dysmorphism, growth retardation, hyperparathyroidism, hypotonia, lactic acidosis, mental retardation. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6643860-6 | Caesarean Section, Cerebral Disorder, Cerebral Ventricle Dilatation, Cleft Palate, Congenital Anomaly, Dysphagia, Foetal Growth Retardation, Hypotonia Neonatal
on Dec 18, 2009 Female patient from , weighting 5.95 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: caesarean section, cerebral disorder, cerebral ventricle dilatation, cleft palate, congenital anomaly, dysphagia, foetal growth retardation, hypotonia neonatal. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR (Transplacent) (View Nelfinavir Review and Nelfinavir Label ), COMBIVIR (View Combivir Review and Combivir Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ), VALCICLOVIR (View Valciclovir Review and Valciclovir Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), AMYLASE (View Amylase Review and Amylase Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), DIOSMECITITE (View Diosmecitite Review and Diosmecitite Label ).

6643858-8 | Atrial Septal Defect, Trisomy 21
on Dec 18, 2009 Female patient from THAILAND , weighting 6.15 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, trisomy 21. Zidovudine dosage: Transplacent. During the same period patient was treated with NELFINAVIR (Transplacent) (View Nelfinavir Review and Nelfinavir Label ), LAMIVUDINE (Transplacental) (View Lamivudine Review and Lamivudine Label ), LOPINOVIR (Transplacental) (View Lopinovir Review and Lopinovir Label ), RITONAVIR (Transplacental) (View Ritonavir Review and Ritonavir Label ).

6641758-0 |
Patient was taking Zidovudine (View Usage). on Mar 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 7.05 lb, was diagnosed with antiviral prophylaxis, hiv infection (What is hiv infection?) and. Zidovudine dosage: Unk. During the same period patient was treated with LAMIVUDINE (Unk) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (Unk) (View Nevirapine Review and Nevirapine Label ), COMBIVIR (Unk) (View Combivir Review and Combivir Label ), KALETRA (Unk) (View Kaletra Review and Kaletra Label ), SEPTRIN (Unk) (View Septrin Review and Septrin Label ), VIRAMUNE (Unk) (View Viramune Review and Viramune Label ).

6636563-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrial Septal Defect, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dehydration, Diarrhoea Neonatal, Metabolic Acidosis
Adverse event was reported on Feb 22, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: 500mg-transplacent) was diagnosed with hiv infection (What is hiv infection?), prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and. Location: INDIA , weighting 3.09 lb, After Zidovudine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial septal defect, blood alkaline phosphatase increased, blood bilirubin increased, dehydration, diarrhoea neonatal, metabolic acidosis. Patient was hospitalized.

6636510-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Caesarean Section, Developmental Delay, Failure To Thrive, Hepatitis, Hepatosplenomegaly, Lactic Acidosis, Lymphadenopathy
on Feb 22, 2010 Female patient from INDIA , weighting 4.63 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, caesarean section, developmental delay, failure to thrive, hepatitis (What is hepatitis?), hepatosplenomegaly, lactic acidosis, lymphadenopathy. Zidovudine dosage: Transplacental. During the same period patient was treated with LAMIVUDINE (8 Mg/kg/day-bid) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (300 Mg/m2/day-bid) (View Nevirapine Review and Nevirapine Label ), COTRIMOXAZOLE [TRIMETHOPRIM/SULFAMETHOXAZOLE] (View Cotrimoxazole [trimethoprim/sulfamethoxazole] Review and Cotrimoxazole [trimethoprim/sulfamethoxazole] Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), STREPTOMYCIN (View Streptomycin Review and Streptomycin Label ).

6622020-9 | Osteonecrosis, Treatment Failure
on Feb 22, 2010 Male patient from COTE D'IVOIRE , 33 years of age, weighting 149.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?), treatment failure. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

6622017-9 | Osteonecrosis
Patient was taking Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Feb 22, 2010 from COTE D'IVOIRE Additional patient health information: Male patient , 45 years of age, weighting 145.2 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: . During the same period patient was treated with ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized.

6619302-3 | Caesarean Section, Mitochondrial Toxicity
Adverse event was reported on Feb 16, 2010 by a Male patient taking Zidovudine (View Usage) (Dosage: Transplacen) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , weighting 7.05 lb, Patient experienced the following unwanted or unexpected effects: caesarean section, mitochondrial toxicity. During the same period patient was treated with COMBIVIR (Transplacen) (View Combivir Review and Combivir Label ), KALETRA (Transplacental) (View Kaletra Review and Kaletra Label ), VIRAMUNE (Transplacental) (View Viramune Review and Viramune Label ), SEPTRIN (View Septrin Review and Septrin Label ).

6609704-3 | Atrial Septal Defect, Caesarean Section, Dehydration, Developmental Delay, Diarrhoea, Hepatitis, Lactic Acidosis, Metabolic Acidosis
on Feb 26, 2010 Female patient from , weighting 4.41 lb, was diagnosed with blood lactate dehydrogenase abnormal and was treated with Zidovudine (View Usage). Patient had the following side effects: atrial septal defect, caesarean section, dehydration, developmental delay, diarrhoea, hepatitis (What is hepatitis?), lactic acidosis, metabolic acidosis. Zidovudine dosage: . During the same period patient was treated with RIBOFLAVIN TAB (View Riboflavin Tab Review and Riboflavin Tab Label ), THIAMINE (View Thiamine Review and Thiamine Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), L CARNITINE (View L-carnitine Review and L-carnitine Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

6609418-X | Caesarean Section, Hepatotoxicity, Toxic Epidermal Necrolysis
on Feb 09, 2010 Female patient from ARGENTINA , 34 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: caesarean section, hepatotoxicity, toxic epidermal necrolysis. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ). Patient was hospitalized.

6595836-5 | Congenital Nail Disorder
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: congenital nail disorder on Jan 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 6.90 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: 1708mg/kg Hr, Transplacental. During the same period patient was treated with NELFINAVIR MESYLATE (2500mg, Qd,transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), SAQUINAVIR (2000mg-transplacental) (View Saquinavir Review and Saquinavir Label ), RITONAVIR (200mg-transplacental) (View Ritonavir Review and Ritonavir Label ), LAMIVUDINE + ZIDOVUDINE (2df-transplacental) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ).

6590676-5 | Atrial Septal Defect, Cardiac Failure Congestive
Adverse event was reported on Feb 12, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: 24mg Four Times Per Day) was diagnosed with antiviral prophylaxis and. Location: THAILAND , weighting 13.67 lb, Patient had the following side effects: atrial septal defect, cardiac failure congestive. During the same period patient was treated with NEVIRAPINE (6mg Per Day) (View Nevirapine Review and Nevirapine Label ).

6590623-6 | Live Birth, Myocardial Infarction
on Feb 11, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: live birth, myocardial infarction. Zidovudine dosage: 160mg Per Day. During the same period patient was treated with REYATAZ (300mg Per Day) (View Reyataz Review and Reyataz Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ), NORVIR (100mg Per Day) (View Norvir Review and Norvir Label ).

6588967-7 | Abdominal Distension, Abdominal Hernia, Cardiac Murmur, Congenital Anomaly, Cryptorchism
on Feb 03, 2010 Male patient from UNITED KINGDOM , weighting 7.43 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. Zidovudine dosage: 600 Mg, 1x/day. During the same period patient was treated with NELFINAVIR MESILATE (2500 Mg, 1x/day) (View Nelfinavir Mesilate Review and Nelfinavir Mesilate Label ), LAMIVUDINE (1200 Mg, 1x/day) (View Lamivudine Review and Lamivudine Label ), KALETRA (600 Mg, 1x/day) (View Kaletra Review and Kaletra Label ), VIREAD (300 Mg, 1x/day) (View Viread Review and Viread Label ), COMBIVIR (600 Mg, 1x/day) (View Combivir Review and Combivir Label ), RETROVIR (600 Mg, 1x/day) (View Retrovir Review and Retrovir Label ), CRIXIVAN (Unk) (View Crixivan Review and Crixivan Label ), TRUVADA (View Truvada Review and Truvada Label ).

6578305-8 | Atrial Septal Defect, Cardiac Failure Congestive
Patient was taking Zidovudine (View Usage). Patient had the following side effects: atrial septal defect, cardiac failure congestive on Feb 03, 2010 from THAILAND Additional patient health information: Female patient , weighting 13.67 lb, was diagnosed with antiviral prophylaxis and. Zidovudine dosage: 24mg Four Times Per Day. During the same period patient was treated with NEVIRAPINE (6mg Per Day) (View Nevirapine Review and Nevirapine Label ).

6578250-8 | Live Birth, Myocardial Infarction
Adverse event was reported on Feb 02, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: 160mg Per Day) was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and. Location: UNITED STATES , 35 years of age, After Zidovudine was administered, patient had the following side effects: live birth, myocardial infarction. During the same period patient was treated with REYATAZ (300mg Per Day) (View Reyataz Review and Reyataz Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ), NORVIR (100mg Per Day) (View Norvir Review and Norvir Label ).

6572180-3 | Hypokinesia, Immune Reconstitution Syndrome, Induration, Nodule, Oedema Peripheral, Osteomyelitis, Skin Ulcer, Sporotrichosis, Tenosynovitis
on Jan 26, 2010 Male patient from BRAZIL , 47 years of age, was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: hypokinesia, immune reconstitution syndrome, induration, nodule, oedema peripheral, osteomyelitis, skin ulcer, sporotrichosis, tenosynovitis. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6570741-9 | Arthralgia, Immune Reconstitution Syndrome, Mucous Membrane Disorder, Skin Lesion, Skin Ulcer, Sporotrichosis
on Jan 26, 2010 Female patient from BRAZIL , 46 years of age, was treated with Zidovudine (View Usage). Patient had the following side effects: arthralgia, immune reconstitution syndrome, mucous membrane disorder, skin lesion, skin ulcer, sporotrichosis. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ITRACONAZOLE (400mg Per Day) (View Itraconazole Review and Itraconazole Label ). Patient was hospitalized.

6556432-9 |
Patient was taking Zidovudine (View Usage). on Jan 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 7.05 lb, . Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6552663-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Transaminases Increased
Adverse event was reported on Jan 25, 2010 by a Female patient taking Zidovudine (View Usage) (Dosage: 70mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: SOUTH AFRICA , weighting 18.74 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, transaminases increased. During the same period patient was treated with LAMIVUDINE (30mg Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (30mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ).

6543511-5 | Anaemia, Haemoglobin Decreased, Irritability, Listless, Pallor, Pyrexia
on Jan 15, 2010 Male patient from INDIA , weighting 19.40 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient had the following side effects: anaemia, haemoglobin decreased, irritability, listless, pallor, pyrexia. Zidovudine dosage: 80mg Twice Per Day. During the same period patient was treated with LAMIVUDINE (30mg Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (90mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6539562-7 | Anaemia, Haemoglobin Decreased, Irritability, Listless, Pallor, Pyrexia
on Jan 12, 2010 Male patient from INDIA , weighting 19.40 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: anaemia, haemoglobin decreased, irritability, listless, pallor, pyrexia. Zidovudine dosage: 80mg Twice Per Day. During the same period patient was treated with LAMIVUDINE (30mg Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (90mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6529932-5 | Alopecia, Cutaneous Lupus Erythematosus, Skin Lesion
Patient was taking Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, cutaneous lupus erythematosus, skin lesion on Dec 15, 2009 from FRANCE Additional patient health information: Female patient , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ).

6525831-3 | Hepatic Enzyme Increased, Treatment Noncompliance
Adverse event was reported on Dec 31, 2009 by a Male patient taking Zidovudine (View Usage) (Dosage: 10ml Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: MALAWI , weighting 22.49 lb, Patient had the following side effects: hepatic enzyme increased, treatment noncompliance. During the same period patient was treated with LAMIVUDINE (4ml Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (10ml Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6523003-X | Abasia, Blood Lactic Acid Increased, Cataract, Developmental Delay, Growth Retardation, Hyperparathyroidism, Hypotonia, Mental Retardation
on Dec 07, 2009 Female patient from UNITED STATES , child 4 years of age, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Zidovudine (View Usage). After Zidovudine was administered, patient had the following side effects: abasia, blood lactic acid increased, cataract (What is cataract?), developmental delay, growth retardation, hyperparathyroidism, hypotonia, mental retardation. Zidovudine dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NELFINAVIR MESYLATE (Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ). Patient was hospitalized.

6517098-7 | Hepatic Enzyme Increased, Treatment Noncompliance
on Dec 16, 2009 Male patient from MALAWI , weighting 22.49 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Zidovudine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, treatment noncompliance. Zidovudine dosage: 10ml Twice Per Day. During the same period patient was treated with LAMIVUDINE (4ml Twice Per Day) (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (10ml Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6504339-5 | Abdominal Distension, Abdominal Wall Anomaly, Cardiac Murmur, Congenital Abdominal Hernia, Congenital Anomaly, Cryptorchism, Exomphalos, Gastroschisis
Patient was taking Zidovudine (View Usage). Patient had the following side effects: abdominal distension, abdominal wall anomaly, cardiac murmur, congenital abdominal hernia, congenital anomaly, cryptorchism, exomphalos, gastroschisis on Nov 21, 2009 from Additional patient health information: Male patient , weighting 7.43 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zidovudine dosage: 600mg 1day Transplacent. During the same period patient was treated with LAMIVUDINE (1.2gm 1day Transplacent) (View Lamivudine Review and Lamivudine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), KALETRA (View Kaletra Review and Kaletra Label ), NELFINAVIR MESYLATE (2500mg Daily Transplacental) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), VIREAD (300mg Daily Transplacental) (View Viread Review and Viread Label ).